CCO Infectious Disease Podcast

RSV Vaccines in Adults: A Risk-Based Approach

Episode Summary

Listen to Angela Branche, MD, share her perspective on why healthcare professionals should consider a risk-based approach—rather than age alone—to determine RSV vaccine candidacy in adults.

Episode Notes

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: 

• Current Advisory Committee on Immunization Practices recommendations
• Risk factors associated with severe RSV disease, including RSV-related hospitalizations
• Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine 
• Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities 
• Health disparities related to RSV vaccines
• Considerations for a risk-based approach, rather than age alone, to determine vaccine candidacy 

Faculty: 

Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Link to full program: 
https://bit.ly/3nb25xe

Link to downloadable slides: 
https://bit.ly/3TsXym5